|
|
|
MIRA INFORM REPORT
|
Report No. : |
493339 |
|
Report Date : |
23.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
ROTTAPHARM LIMITED |
|
|
|
|
Registered Office : |
Damastown Industrial
Park, Mulhuddart, Dublin 15 662871 |
|
|
|
|
Country : |
Ireland |
|
|
|
|
Financials (as on) : |
31.12.2016 |
|
|
|
|
Date of Incorporation : |
13.12.1994 |
|
|
|
|
Com. Reg. No.: |
IE226092 |
|
|
|
|
Legal Form : |
Ltd - Private Company Limited by Shares |
|
|
|
|
Line of Business : |
The production and sale, on behalf of the parent
undertaking, of various drugs. |
|
|
|
|
No. of Employees : |
139 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
Ireland |
A2 |
A2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
IRELAND - ECONOMIC OVERVIEW
Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity dropped sharply during the world financial crisis and the subsequent collapse of its domestic property market and construction industry. Faced with sharply reduced revenues and a burgeoning budget deficit from efforts to stabilize its fragile banking sector, the Irish Government introduced the first in a series of draconian budgets in 2009. These measures were not sufficient to stabilize Ireland’s public finances. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP. In late 2010, the former COWEN government agreed to a $92 billion loan package from the EU and IMF to help Dublin recapitalize Ireland’s banking sector and avoid defaulting on its sovereign debt. In March 2011, the KENNY government intensified austerity measures to meet the deficit targets under Ireland's EU-IMF bailout program.
In late 2013, Ireland formally exited its EU-IMF bailout program, benefiting from its strict adherence to deficit-reduction targets and success in refinancing a large amount of banking-related debt. In 2014, the economy rapidly picked up and GDP grew by 25% in 2015. In late 2014, the government introduced a fiscally neutral budget, marking the end of the austerity program. Continued growth of tax receipts has allowed the government to lower some taxes and increase public spending while keeping to its deficit-reduction targets. In 2015, GDP growth exceeded 26%. This increase reflected one-off statistical revisions, multinational corporate restructurings, and the aircraft leasing sector, rather than gains in the on the ground economy. Growth moderated to around 4.1% in 2017, but the recovering economy assisted lowering the deficit to 0.6% of GDP.
In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become an even more important component of Ireland's economy. Ireland’s low corporation tax of 12.5% and a talented pool of high-tech laborers have been key factors in encouraging business investment. Loose tax residency requirements made Ireland a common destination for international firms seeking to avoid taxation. In 2014, amid growing international pressure, the government announced it would phase in more stringent tax laws, effectively closing a commonly used loophole.
|
Source
: CIA |
COMPANY NAME AND ADDRESS
Company
Name: ROTTAPHARM LIMITED
Company
No: IE226092
Company
Status: Active - Accounts Filed
Registered
Address: DAMASTOWN INDUSTRIAL PARKMULHUDDARTDUBLIN 15662871
Company Summary
Registered
Address DAMASTOWN INDUSTRIAL PARK, MULHUDDART, DUBLIN 15 662871
Trading
Address DOMASTOWN INDUSTRIAL PARK, MULHUDDART, DUBLIN 15 216410
Website
Address -
Eircode
-
VAT
Number IE8226092M
Telephone
Number -
Fax
Number -
TPS
No
FPS
Yes
Incorporation
Date 13/12/1994
Previous
Name -
Type LTD - PRIVATE COMPANY LIMITED BY
SHARES
FTSE
Index -
Date
of Change -
Filing
Date of Accounts -
Currency
EUR
Share
Capital €617,241
SIC07
-
Charity
Number -
SIC07
Description -
Principal
Activity The production and sale, on behalf of the parent
undertaking, of various drugs.
Nace
Code -
Nace
Description -
Additional Information
CJ's
0 (€0)
No
CJ Information To Display
Ultimate
Holding Company MEDA AKTIEBOLAG
Accountant
-
Mortgages
1
Group
8
companies
Linkages
94
companies
Countries
In 29
countries
Key Financials
Year to Date Turnover Pre
Tax Profit Shareholder's Funds Employees
31/12/2016
€74,769,235 €52,980,352 €1,363,180,499
139
31/12/2015
€83,150,375 €6,200,284 €564,414,702
143
31/12/2014
€71,609,690 €26,200,160 €359,470,145
128
Mortgage Summary
Total
Mortgage 1
Outstanding 0
Satisfied 1
Trade Debtors / Bad Debt Summary
Total
Number of Documented Trade 0
Total
Value of Documented Trade €0
Commentary
|
No
exact match CCJs are recorded against the company. |
|
Net
Worth increased by 150% during the latest trading period. |
|
A
118.6% growth in Total Assets occurred during the latest trading period. |
CJ
|
Total
Number of Exact CJs - |
0 |
Total
Value of Exact CJs - |
€0 |
|
Total
Number of Possible CJs - |
0 |
Total
Value of Possible CJs - |
€0 |
|
Total
Number of Satisfied CJs - |
0 |
Total
Value of Satisfied CJs - |
€0 |
|
Total
Current Directors |
5 |
Total
Current Secretaries |
1 |
|
Total
Previous Directors / Company Secretaries |
11 |
Current Directors
|
Title |
Function |
Director |
|
|
Name |
ROBERT
BURKE |
Nationality |
|
|
Date
of Birth |
03/1946 |
Present
Appointments |
65 |
|
Latest
Address |
33
BROOK COURT, MONKSTOWN., CO. DUBLIN. |
Appointment
Date |
27/03/2015 |
|
Eircode |
|||
|
|
|
|
|
|
Title |
Function |
Director |
|
|
Name |
PATRICK
GARRAHY |
Nationality |
|
|
Date
of Birth |
02/1961 |
Present
Appointments |
1 |
|
Latest
Address |
DEERPARK,
HOWTH, DUBLIN 13. |
Appointment
Date |
27/03/2015 |
|
Eircode |
|||
|
|
|
|
|
|
Title |
Function |
Director |
|
|
Name |
DAN
MARTEN OSTERLUND |
Nationality |
|
|
Date
of Birth |
12/1957 |
Present
Appointments |
1 |
|
Latest
Address |
LANGANGSVAGEN
24, 125 56 ALVSJO, SWEDEN |
Appointment
Date |
11/11/2014 |
|
Eircode |
|||
|
|
|
|
|
|
Title |
Function |
Director |
|
|
Name |
OWEN
MCKEON |
Nationality |
|
|
Date
of Birth |
10/1958 |
Present
Appointments |
1 |
|
Latest
Address |
THE
OLD RECTORY, HOLMPATRICK, MILLER'S LANE, SKERRIES |
Appointment
Date |
11/11/2014 |
|
Eircode |
|||
|
|
|
||
|
Title |
Function |
Director |
|
|
Name |
ANTHONIUS
MATTHIJS VAN'T HULLENAAR |
Nationality |
|
|
Date
of Birth |
05/1955 |
Present
Appointments |
1 |
|
Latest
Address |
MANSTEDTENER
BERG 12, 50259 PULHEIM, GERMANY |
Appointment
Date |
11/11/2014 |
|
Eircode |
|||
Current Company Secretary
|
Title |
Function |
Company
Secretary |
|
|
Name |
DEREK
MOLLOY |
Nationality |
|
|
Date
of Birth |
- |
Present
Appointments |
1 |
|
Latest
Address |
22
NEWLANDS PARK, CLONDALKIN, DUBLIN 22. |
Appointment
Date |
07/10/2013 |
|
Eircode |
Top Shareholders
|
Name |
Currency |
Share Count |
Share Type |
Nominal Value |
% of Total Share
Count |
|
ROTTAPHARM
S.P.A. |
EUR |
617,241 |
ORDINARY
|
1 |
100 |
FINANCIALS
PROFIT & LOSS
|
Date Of Accounts |
31/12/16 |
(%) |
31/12/15 |
(%) |
31/12/14 |
(%) |
31/12/13 |
(%) |
31/12/12 |
|
|
Weeks |
52 |
(%) |
52 |
(%) |
52 |
(%) |
52 |
(%) |
52 |
|
|
Currency |
EUR |
(%) |
EUR |
(%) |
EUR |
(%) |
EUR |
(%) |
EUR |
|
|
Consolidated A/cs |
N |
(%) |
N |
(%) |
N |
(%) |
N |
(%) |
N |
|
|
|
Turnover |
€74,769,235 |
-10.1% |
€83,150,375 |
16.1% |
€71,609,690 |
3.4% |
€69,288,163 |
7.9% |
€64,229,147 |
|
|
Export |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Cost
of Sales |
€47,133,515 |
-7.7% |
€51,087,513 |
5% |
€48,635,381 |
11.4% |
€43,670,974 |
8.3% |
€40,323,576 |
|
|
Gross
Profit |
€27,635,720 |
-13.8% |
€32,062,862 |
39.6% |
€22,974,309 |
-10.3% |
€25,617,189 |
7.2% |
€23,905,571 |
|
|
Wages
& Salaries |
€9,360,736 |
0.6% |
€9,309,229 |
32.5% |
€7,025,070 |
0.4% |
€7,000,163 |
-1.1% |
€7,077,327 |
|
|
Directors
Emoluments |
€350,750 |
39.9% |
€250,776 |
-1.8% |
€255,351 |
-10% |
€283,775 |
3.1% |
€275,294 |
|
|
Operating
Profit |
€17,894,953 |
-31.9% |
€26,266,203 |
102.6% |
€12,966,773 |
-27.1% |
€17,793,739 |
-15% |
€20,922,524 |
|
|
Depreciation |
€2,397,343 |
15.3% |
€2,078,769 |
13.8% |
€1,826,128 |
-15.1% |
€2,150,659 |
5.8% |
€2,033,256 |
|
|
Audit
Fees |
€40,000 |
- |
€40,000 |
-50.1% |
€80,220 |
14.6% |
€70,000 |
- |
€70,000 |
|
|
Interest
Payments |
€7,631,264 |
-85.1% |
€51,243,566 |
98.3% |
€25,845,378 |
0.3% |
€25,760,459 |
264.3% |
€7,072,034 |
|
|
Pre
Tax Profit |
€52,980,352 |
754.5% |
€6,200,284 |
-76.3% |
€26,200,160 |
-13.3% |
€30,235,385 |
-18.6% |
€37,144,566 |
|
|
Taxation |
-€6,868,776 |
-999.9% |
-€371,236 |
91.2% |
-€4,223,495 |
16.4% |
-€5,055,040 |
-196.1% |
€5,261,631 |
|
|
Profit
After Tax |
€46,111,576 |
691.1% |
€5,829,048 |
-73.5% |
€21,976,665 |
-12.7% |
€25,180,345 |
-40.6% |
€42,406,197 |
|
|
Dividends
Payable |
- |
- |
- |
-100% |
€10,000,000 |
- |
€10,000,000 |
999.9% |
€61,674 |
|
|
Retained
Profit |
€46,111,576 |
691.1% |
€5,829,048 |
-51.3% |
€11,976,665 |
-21.1% |
€15,180,345 |
-64.2% |
€42,344,523 |
BALANCE SHEET
|
Date Of Accounts |
31/12/16 |
(%) |
31/12/15 |
(%) |
31/12/14 |
(%) |
31/12/13 |
(%) |
31/12/12 |
|
|
|
Tangible
Assets |
€1,588,892,287 |
155.3% |
€622,315,398 |
23.2% |
€505,299,491 |
-10.7% |
€565,916,833 |
35.4% |
€417,850,212 |
|
|
Intangible
Assets |
€24,052,618 |
-16.5% |
€28,812,479 |
-12.3% |
€32,860,459 |
-6.8% |
€35,267,199 |
129.5% |
€15,369,293 |
|
|
Total
Fixed Assets |
€1,612,944,905 |
147.7% |
€651,127,877 |
21% |
€538,159,950 |
-10.5% |
€601,184,032 |
38.8% |
€433,219,505 |
|
|
Stock |
€14,829,248 |
0.6% |
€14,735,529 |
-7.4% |
€15,916,105 |
22.8% |
€12,956,730 |
-10% |
€14,389,675 |
|
|
Trade
Debtors |
€4,603,227 |
-30.5% |
€6,623,997 |
7% |
€6,192,149 |
-2% |
€6,318,359 |
-7.4% |
€6,821,534 |
|
|
Cash |
€27,119,269 |
251.8% |
€7,707,971 |
-85.1% |
€51,582,379 |
138.1% |
€21,667,127 |
-43.9% |
€38,626,839 |
|
|
Other
Debtors |
€163,562,110 |
7.2% |
€152,609,569 |
-4.1% |
€159,071,921 |
40% |
€113,586,283 |
-52.9% |
€240,955,446 |
|
|
Miscellaneous
Current Assets |
€1,354,405 |
-22.6% |
€1,749,581 |
-67.8% |
€5,432,219 |
165.7% |
€2,044,661 |
-44.7% |
€3,699,821 |
|
|
Total
Current Assets |
€211,468,259 |
15.3% |
€183,426,647 |
-23% |
€238,194,773 |
52.1% |
€156,573,160 |
-48.6% |
€304,493,315 |
|
|
Trade
Creditors |
€2,973,060 |
-30.9% |
€4,304,384 |
-34.1% |
€6,530,148 |
57.8% |
€4,138,316 |
73.2% |
€2,389,034 |
|
|
Bank
Loans & Overdrafts |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|
Other
Short Term Finance |
€454,354,193 |
72.2% |
€263,779,320 |
999.9% |
€9,073,994 |
46.4% |
€6,198,998 |
14.5% |
€5,414,475 |
|
|
Miscellaneous
Current Liabilities |
€3,102,302 |
162.3% |
€1,182,666 |
-74.5% |
€4,645,888 |
-38% |
€7,498,712 |
20.1% |
€6,242,079 |
|
|
Total
Current Liabilities |
€460,429,555 |
71% |
€269,266,370 |
999.9% |
€20,250,030 |
13.5% |
€17,836,026 |
27% |
€14,045,588 |
|
|
Bank
Loans & Overdrafts and LTL |
€803,110 |
-8.1% |
€873,452 |
-99.8% |
€396,634,548 |
0.9% |
€393,248,653 |
0.3% |
€392,180,756 |
|
|
Other
Long Term Finance |
0 |
- |
0 |
-100% |
€393,411,640 |
0.3% |
€392,409,807 |
0.3% |
€391,387,663 |
|
|
Total
Long Term Liabilities |
€803,110 |
-8.1% |
€873,452 |
-99.8% |
€396,634,548 |
0.9% |
€393,248,653 |
0.3% |
€392,180,756 |
CAPITAL &
RESERVES
|
Date Of Accounts |
31/12/16 |
(%) |
31/12/15 |
(%) |
31/12/14 |
(%) |
31/12/13 |
(%) |
31/12/12 |
|
|
|
Called
Up Share Capital |
€617,241 |
94.4% |
€317,500 |
- |
€317,500 |
- |
€317,500 |
- |
€317,500 |
|
|
P
& L Account Reserve |
€281,720,446 |
19.6% |
€235,608,870 |
2.5% |
€229,779,822 |
5.5% |
€217,803,272 |
7.5% |
€202,622,927 |
|
|
Revaluation
Reserve |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Sundry
Reserves |
€1,080,842,812 |
229% |
€328,488,332 |
153.9% |
€129,372,823 |
0.6% |
€128,551,741 |
0% |
€128,546,049 |
|
|
Shareholder
Funds |
€1,363,180,499 |
141.5% |
€564,414,702 |
57% |
€359,470,145 |
3.7% |
€346,672,513 |
4.6% |
€331,486,476 |
OTHER FINANCIAL ITEMS
|
Date Of Accounts |
31/12/16 |
(%) |
31/12/15 |
(%) |
31/12/14 |
(%) |
31/12/13 |
(%) |
31/12/12 |
|
|
|
Net
Worth |
€1,339,127,881 |
150% |
€535,602,223 |
64% |
€326,609,686 |
4.9% |
€311,405,314 |
-1.5% |
€316,117,183 |
|
|
Working
Capital |
-€248,961,296 |
-190% |
-€85,839,723 |
-139.4% |
€217,944,743 |
57.1% |
€138,737,134 |
-52.2% |
€290,447,727 |
|
|
Total
Assets |
€1,824,413,164 |
118.6% |
€834,554,524 |
7.5% |
€776,354,723 |
2.5% |
€757,757,192 |
2.7% |
€737,712,820 |
|
|
Total
Liabilities |
€461,232,665 |
70.7% |
€270,139,822 |
-35.2% |
€416,884,578 |
1.4% |
€411,084,679 |
1.2% |
€406,226,344 |
|
|
Net
Assets |
€1,363,180,499 |
141.5% |
€564,414,702 |
57% |
€359,470,145 |
3.7% |
€346,672,513 |
4.6% |
€331,486,476 |
CASH FLOW
|
Date Of Accounts |
31/12/16 |
(%) |
31/12/15 |
(%) |
31/12/14 |
(%) |
31/12/13 |
(%) |
31/12/12 |
|
|
|
Net
Cashflow from Operations |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Net
Cashflow before Financing |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Net
Cashflow from Financing |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Increase
in Cash |
- |
- |
- |
- |
- |
- |
- |
- |
- |
MISCELLANEOUS
|
Date Of Accounts |
31/12/16 |
(%) |
31/12/15 |
(%) |
31/12/14 |
(%) |
31/12/13 |
(%) |
31/12/12 |
|
|
Contingent
Liability |
NO |
- |
NO |
- |
NO |
- |
YES |
- |
YES |
|
|
|
Capital
Employed |
€1,363,983,609 |
141.3% |
€565,288,154 |
-25.2% |
€756,104,693 |
2.2% |
€739,921,166 |
2.2% |
€723,667,232 |
|
|
Number
of Employees |
139 |
-2.8% |
143 |
11.7% |
128 |
- |
128 |
-3% |
132 |
|
Accountants |
||||||||||
|
Auditors |
DELOITTE |
|||||||||
|
Auditor
Comments |
The
audit report contains no adverse comments |
|||||||||
|
Bankers |
ALLIED
IRISH BANK |
|||||||||
|
Bank
Branch Code |
93-25-15 |
|||||||||
RATIOS
|
Date Of Accounts |
31/12/16 |
31/12/15 |
31/12/14 |
31/12/13 |
31/12/12 |
|
|
|
Pre-tax
profit margin % |
70.86 |
7.46 |
36.59 |
43.64 |
57.83 |
|
|
Current
ratio |
0.46 |
0.68 |
11.76 |
8.78 |
21.68 |
|
|
Sales/Net
Working Capital |
-0.30 |
-0.97 |
0.33 |
0.50 |
0.22 |
|
|
Gearing
% |
0.10 |
0.20 |
110.30 |
113.40 |
118.30 |
|
|
Equity
in % |
75.70 |
70 |
48.30 |
48 |
45.90 |
|
|
Creditor
Days |
14.47 |
18.84 |
33.19 |
21.74 |
13.53 |
|
|
Debtor
Days |
22.40 |
28.99 |
31.47 |
33.19 |
38.65 |
|
|
Liquidity/Acid
Test |
0.42 |
0.62 |
10.97 |
8.05 |
20.65 |
|
|
Return
On Capital Employed % |
3.88 |
1.09 |
3.46 |
4.08 |
5.13 |
|
|
Return
On Total Assets Employed % |
2.90 |
0.74 |
3.37 |
3.99 |
5.03 |
|
|
Current
Debt Ratio |
0.33 |
0.47 |
0.05 |
0.05 |
0.04 |
|
|
Total
Debt Ratio |
0.33 |
0.47 |
1.15 |
1.18 |
1.22 |
|
|
Stock
Turnover Ratio % |
19.83 |
17.72 |
22.22 |
18.69 |
22.40 |
|
|
Return
on Net Assets Employed % |
3.88 |
1.09 |
7.28 |
8.72 |
11.20 |
Report Notes
There
are no notes to display.
Status History
No
Status History found
Event History
|
Date |
Description |
|
26/06/2017 |
Annual
Returns |
|
26/06/2017 |
New
Accounts Filed |
|
26/06/2017 |
New
Accounts Filed |
|
01/08/2016 |
New
Accounts Filed |
|
01/08/2016 |
New
Accounts Filed |
|
28/07/2016 |
Annual
Returns |
|
10/10/2015 |
New
Accounts Filed |
|
09/10/2015 |
Annual
Returns |
|
27/03/2015 |
New
Board Member (ROBERT BURKE) appointed |
|
27/03/2015 |
New
Board Member (PATRICK GARRAHY) appointed |
|
11/11/2014 |
ROBERT
HERBERT BURKE has left the board |
|
11/11/2014 |
PETER
DEKKER has left the board |
|
11/11/2014 |
SIGIERI
DIAZ DELLA VITTORIA PALLAVICINI has left the board |
|
11/11/2014 |
PATRICK
GARRAHY has left the board |
|
11/11/2014 |
New
Board Member (ANTHONIUS MATTHIJS VAN'T HULLENAAR) appointed |
Previous Company Names
|
No
Previous Names found |
Writ Details
|
No
writs found |
Statistics
|
Group
|
8
companies |
|
Linkages
|
94
companies |
|
Countries
|
In
29 countries |
Summary
|
Holding
Company |
-
|
|
Ownership
Status |
Wholly
Owned |
|
Ultimate
Holding Company |
MEDA
AKTIEBOLAG |
Group Structure Full
|
Company Name |
Registered Number |
Latest Key
Financials |
Consol. Accounts |
Turnover |
|
|
|
|
5564272812
|
31.12.2016 |
Y |
6,346,000
KSEK |
|
|
|
IE403901
|
31.12.2015 |
N |
|
|
|
|
N/A
|
- |
- |
|
|
|
|
SC043236
|
31.12.2016 |
N |
£56,703,000
|
|
|
|
04157106
|
31.12.2016 |
N |
|
|
|
|
N/A
|
- |
- |
|
|
|
|
IE226092
|
31.12.2016 |
N |
€74,769,235
|
|
|
|
04303411
|
31.12.2016 |
N |
Business Owner Links
|
Business Name |
Business No |
Business Status. |
|
ROTTAPHARM
LIMITED |
IE226092
|
|
|
ROTTAPHARM IRELAND |
555047
|
NORMAL |
|
ROTTAPHARM |
555049
|
NORMAL |
|
MEDA MANUFACTURING DUBLIN |
555048
|
NORMAL |
Statistics
|
Group
|
8
companies |
|
Linkages
|
94
companies |
|
Countries
|
In
29 countries |
Other Linked Companies
|
Name |
Number |
Latest Key
Financials |
Turnover |
|
|
MEDA
PHARMA SA |
|
403048064
|
31.12.2016 |
€62,833,220
|
|
MEDA
PHARMA |
|
B157784
|
31.12.2016 |
|
|
MEDA
HOLDING |
|
442674339
|
31.12.2016 |
|
|
MEDA
HOLDING |
|
442674339
|
31.12.2016 |
|
|
MADAUS
GMBH |
|
HRB
9054 |
31.12.2016 |
€141,216,669
|
|
MADAUS
HOLDING GMBH |
|
HRB
61153 |
31.12.2012 |
|
|
MEDA
PHARMA S.P.A. |
|
MI257394
|
31.12.2015 |
€150,186,851
|
|
ROTTAPHARM
S.P.A. |
|
MI1018616
|
31.12.2015 |
€250,333,783
|
|
MEDA
PHARMA |
|
456204569
|
31.12.2016 |
€172,677,527
|
|
ROTTAPHARM
I MADAUS GMBH |
|
HRB
38787 |
31.12.2015 |
€21,380,523
|
|
FIDIM
SRL |
|
MI1222837
|
31.12.2016 |
€162,832
|
|
MEDA
AS |
|
920218199
|
31.12.2016 |
318,181
KNOK |
|
MEDA
MANUFACTURING GMBH |
|
HRB
32565 |
31.12.2016 |
€62,551,907
|
|
BGP
PRODUCTS AB |
|
5569841728
|
31.12.2016 |
136,403
KSEK |
|
MEDA
GERMANY HOLDING GMBH |
|
HRB
9848 |
31.12.2015 |
|
|
RRL
IMMOBILIARE S.P.A. |
|
MB1725570
|
31.12.2016 |
€5,470,045
|
|
ATLANTICA
PROPERTIES S.P.A. |
|
MB1900736
|
31.12.2016 |
€23,592,459
|
|
MADAUS
PHARMA SA |
|
406094953
|
31.12.2014 |
€13,576,503
|
|
MEDA
OTC AB |
|
5565294773
|
31.12.2016 |
97,625
KSEK |
|
MEDA
OY |
|
01114579
|
31.12.2016 |
€32,658,000
|
Mortgage Details
|
Mortgage
Type: |
A
charge on book debts of the company. |
||
|
Date
Charge Created: |
06/12/10 |
||
|
Date
Charge Registered: |
15/12/10 |
||
|
Date
Charge Satisfied: |
29/06/17 |
||
|
Status: |
FULLY
SATISFIED |
||
|
Person(s)
Entitled: |
CREDIT
SUISSE AG |
||
|
Amount
Secured: |
|||
|
Details: |
All
monies and/or obligations which now are, or at any time may become, due or
owing to the security holder by the company on any account and all the other
liabilities whatsoever of the company to the security holder whether actual
or contingent and whether as principal debtor, guarantor, surety or
otherwise. |
||
Previous Director/Company Secretaries
|
Name |
Current
Active Appointments |
Previous
Appointments |
Dissolved
Companies |
|
ROBERT
HERBERT BURKE |
11 |
29 |
124 |
|
JOHN
POWER |
4 |
12 |
50 |
|
PETER
DEKKER |
0 |
1 |
1 |
|
LUCA
ROVATI |
0 |
1 |
1 |
|
MARK
PEARSON |
5 |
35 |
89 |
|
PATRICK
GARRAHY |
1 |
1 |
0 |
|
DEREK
MOLLOY |
0 |
1 |
0 |
|
DOMINIC
GERARD CARROLL |
0 |
2 |
2 |
|
DEREK
MOLLOY |
1 |
1 |
0 |
|
ROBERTO
BONFANTI |
0 |
1 |
0 |
|
SIGIERI
DIAZ DELLA VITTORIA PALLAVICINI |
0 |
1 |
0 |
|
Average
Invoice Value |
€157891.93
|
|
Invoices
available |
70
|
|
Paid
|
66
|
|
Outstanding
|
4
|
|
Trade
Payment Data is information that we collect from selected third party
partners who send us information about their whole sales ledger. |
|
Within
Terms |
0-30
Days |
31-60
Days |
61-90
Days |
91+
Days |
|
|
Paid |
61 |
4 |
1 |
0 |
0 |
|
Outstanding |
1 |
0 |
3 |
0 |
0 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 65.05 |
|
|
1 |
INR 90.41 |
|
Euro |
1 |
INR 79.83 |
|
EURO |
1 |
INR 79.78 |
Note:
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.